Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals Market Cap : 857.53M for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 857.53M |
| November 16, 2026 | 893.79M |
| November 13, 2026 | 897.16M |
| November 12, 2026 | 895.47M |
| November 11, 2026 | 967.14M |
| November 10, 2026 | 958.71M |
| November 09, 2026 | 957.03M |
| November 06, 2026 | 888.73M |
| November 05, 2026 | 820.43M |
| November 04, 2026 | 891.26M |
| November 03, 2026 | 828.86M |
| November 02, 2026 | 815.97M |
| October 30, 2026 | 843.73M |
| October 29, 2026 | 860.56M |
| October 28, 2026 | 884.95M |
| October 27, 2026 | 886.63M |
| October 26, 2026 | 879.06M |
| October 23, 2026 | 885.79M |
| October 22, 2026 | 895.89M |
| October 21, 2026 | 845.42M |
| October 20, 2026 | 860.56M |
| October 19, 2026 | 811.77M |
| October 16, 2026 | 800.83M |
| October 15, 2026 | 828.59M |
| October 14, 2026 | 789.05M |
| Date | Value |
|---|---|
| October 13, 2026 | 791.58M |
| October 12, 2026 | 845.42M |
| October 09, 2026 | 884.95M |
| October 08, 2026 | 858.87M |
| October 07, 2026 | 875.70M |
| October 06, 2026 | 888.32M |
| October 05, 2026 | 903.46M |
| October 02, 2026 | 916.92M |
| October 01, 2026 | 919.44M |
| September 30, 2026 | 969.07M |
| September 29, 2026 | 989.26M |
| September 28, 2026 | 998.52M |
| September 25, 2026 | 977.48M |
| September 24, 2026 | 992.63M |
| September 23, 2026 | 1.055B |
| September 22, 2026 | 1.131B |
| September 21, 2026 | 1.045B |
| September 18, 2026 | 1.057B |
| September 17, 2026 | 1.056B |
| September 16, 2026 | 1.029B |
| September 15, 2026 | 1.089B |
| September 14, 2026 | 1.103B |
| September 11, 2026 | 1.086B |
| September 10, 2026 | 1.089B |
| September 09, 2026 | 1.121B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 226.83M |
| CytomX Therapeutics, Inc. | 422.83M |
| ACADIA Pharmaceuticals, Inc. | 3.166B |
| Alnylam Pharmaceuticals, Inc. | 20.95B |
| Anika Therapeutics, Inc. | 172.11M |
Market Cap Related Metrics
| PEG Ratio | -0.4221 |
| Price to Book Value | 4.116 |
| Price | 10.17 |
| Earnings Yield | -7.03% |
| PEGY Ratio | -0.4221 |